Safety and Pharmacokinetic Study of HIV Prophylaxis Using Antiretroviral Intravaginal Rings in Healthy Women

NCT02431273 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Human Immunodeficiency Virus (HIV) Prophylaxis

Interventions

DRUG: TDF IVR
DRUG: TDF-FTC IVR
DRUG: TDF-FTC-MVC IVR

Sponsor

Auritec Pharmaceuticals

Collaborators

[object Object]
[object Object]
[object Object]